Cipla inches up on expanding partnership with Roche Pharma

18 Jun 2020 Evaluate
Cipla is currently trading at Rs. 641.10, up by 0.60 points or 0.09% from its previous closing of Rs. 640.50 on the BSE.
 
The scrip opened at Rs. 638.00 and has touched a high and low of Rs. 644.20 and Rs. 636.75 respectively. So far 53135 shares were traded on the counter.
 
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 669.65 on 05-Jun-2020 and a 52 week low of Rs. 356.75 on 13-Mar-2020.
 
Last one week high and low of the scrip stood at Rs. 653.15 and Rs. 618.85 respectively. The current market cap of the company is Rs. 51516.69 crore.
 
The promoters holding in the company stood at 36.68%, while Institutions and Non-Institutions held 40.61% and 22.71% respectively.
 
Roche Pharma India has expanded its partnership with domestic pharma major Cipla to further improve access to its key oncology medicines in India. Roche Pharma India has signed a distribution agreement with Cipla to expand the scope of the partnership to include, marketing and distribution of its trademark oncology drugs - trastuzumab (Herclon), bevacizumab (Avastin) and rituximab (Ristova) in India.
 
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1500.00 -7.25 (-0.48%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×